Jardine Matheson, a prominent investment conglomerate, has officially announced its agreement to purchase the Australian medical imaging provider, I-MED Radiology Network. This substantial transaction is valued at an enterprise figure of A$3.4 billion, equivalent to $2.4 billion USD, marking a significant entry for Jardine Matheson into the healthcare diagnostics industry. The acquisition underscores the group's strategic focus on broadening its portfolio with leading businesses and exploring new avenues for expansion, particularly within the burgeoning healthcare sector.

The comprehensive deal entails Jardine Matheson acquiring complete ownership of I-MED from its current stakeholders, including funds managed by the private equity firm Permira. Funding for this significant investment will be sourced from Jardine Matheson's existing cash reserves and through debt financing. A key component of this acquisition is I-MED's minority ownership in Harrison.ai, a company at the forefront of developing artificial intelligence solutions for radiology. This inclusion aligns seamlessly with Jardine Matheson's stated objective of securing controlling stakes in dominant market entities and venturing into high-growth segments. The transaction is projected to achieve regulatory approvals and finalize later in 2026, indicating a forward-looking strategy that anticipates long-term benefits and market influence.

The valuation of I-MED stands at approximately 11.5 times its anticipated adjusted EBITDA for the fiscal year concluding June 2026, excluding the Harrison.ai interest. This financial metric highlights the robust performance and future potential that Jardine Matheson sees in the radiology network. The company has expressed that, in its first full year post-completion, the deal is expected to be neutral to its underlying earnings per share, with subsequent years demonstrating accretion. Lincoln Pan, the Chief Executive Officer of Jardine Matheson, who assumed his role in December, emphasized I-MED's current leadership position in the radiology market and expressed confidence in its future growth, both in its established markets and in new territories.

I-MED Radiology Network operates an extensive network of 215 diagnostic imaging clinics across Australia and New Zealand, conducting over 7 million procedures annually. Furthermore, the network provides teleradiology services, enabling the remote interpretation of medical scans, across Australia, New Zealand, and the United States. This broad operational scope and advanced service offerings were undoubtedly key attractions for Jardine Matheson. This latest acquisition follows Jardine Matheson's successful buyout of Mandarin Oriental earlier in January, further demonstrating its active strategy of portfolio enhancement and strategic investments.

This strategic acquisition represents a pivotal moment for Jardine Matheson, signaling its strong intent to diversify beyond its traditional sectors of property, retail, and automotive. By integrating a leading medical imaging provider into its holdings, the group is positioning itself to capitalize on the increasing demand for healthcare services and technological advancements in medical diagnostics. The inclusion of Harrison.ai's AI capabilities further illustrates Jardine Matheson's forward-thinking approach, aiming to leverage innovation for sustained growth and market leadership within the rapidly evolving global healthcare landscape.